|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/0095 | (2013.01) |
| A61K 9/127 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/127 | (2013.01) | ||
| A61K 31/685 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/683 | (2013.01) | ||
| A61K 31/683 | (2006.01) | ||
| A61K 31/685 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/445 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/02 | (2018.01) | ||
| A61K 31/12 | (2006.01) | ||
| A61P 9/04 | (2018.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61P 9/06 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 9/02 | (2006.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 9/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/08 | (2006.01) |
| (11) | Patento numeris | 3697386 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18868801.4 |
| Europos patento paraiškos padavimo data | 2018-10-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-08-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-07-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/056721 |
| Data | 2018-10-19 |
| (87) | Numeris | WO 2019/079726 |
| Data | 2019-04-25 |
| (30) | Numeris | Data | Šalis |
| 201715788683 | 2017-10-19 | US |
| (72) |
HELSON, Lawrence , US
SHOPP, George, M. , US
BOUCHARD, Annie , CA
MAJEED, Muhammed , US
|
| (73) |
Signpath Pharma, Inc. ,
9710 Ruskin Circle, Sandy, UT 84092,
US
|
| (54) | LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTS |
| LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTS |